In the latest Cancer Matters podcast, Dr Bill Nelson talks with Dr Janis Taube and Dr Alex Szalay about AstroPath, a new platform that combines astronomy with pathology to identify predictive biomarkers for cancer immunotherapy.
immunotherapy
New Advances in Therapies: Five-Drug Combo
Posted by | precision medicine, Research, treatmentArnold’s advanced pancreas cancer that had spread to his liver was eliminated with a low-dose, five-drug combination being studied in a clinical trial led by Dung Le. Le is now testing new iterations of the therapy to see if she can help more patients. A new drug cocktail adds immunotherapy and a PARP inhibitor to […]
Immune Cells Hampered When Fighting Soft Tissue and Bone Sarcomas
Posted by | Issues & Perspectives, treatmentResearchers at the Johns Hopkins Kimmel Cancer Center are studying the immune system to find what does and doesn't work to better fight soft tissue & bone cancer. “The basis of successful immunotherapy lies in the ability of the immune system to recognize cancer as foreign and attack, and is dependent on genetics, host and […]
OSONDU: The Race for Life (Part 3)
Posted by | Patient StoriesClement Okoh is a cancer survivor, author, entrepreneur….and proud grandfather. Cancer Matters is sharing book excerpts of his personal journey, “OSONDU,", an inspiring story of hope. Photo: Me with RN's Michaella Iacoboni and Manny Bravo. Read part 1 here: PART 1, PART 2 -- OSONDU – Agency, Hope and Survival (part 3) It’s nearly impossible […]
Cancer Matters with Dr. Bill Nelson – Advances in Lung Cancer
Posted by | podcastIn this Cancer Matters podcast, Dr Bill Nelson talks with Dr Julie Brahmer about the advances made in treating patients with lung cancer, smoking cessation and lung cancer screening.
On Target with Dr. Akila Viswanathan – Brain Cancer
Posted by | podcastIn the next On Target podcast, Dr Akila Viswanathan speaks with Dr Lawrence Kleinberg about the treatment of brain cancer and engaging the immune system to combat tumors.
Meet Janice Paulshock: Twenty-Year Advanced Stage Ovarian Cancer Survivor
Posted by | Patient Stories, SurvivorshipJanice Paulshock is a busy woman. The 58-year-old resident of Harford County, a Maryland suburb, works full-time; is a committed mother and grandmother; runs to keep in shape; participates in charity bike rides to raise money for multiple sclerosis, from which her husband suffers; and volunteers to support current patients and medical students at Johns […]
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Posted by | Issues & Perspectives, precision medicine, Prevention/Screening, treatmentCombinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research […]
Benefits of Immunotherapy in Metastatic Non-Small Cell Lung Cancer
Posted by | Issues & Perspectives, Research, SurvivorshipJulie Brahmer, M.D., is an active clinical leader in the treatment of lung cancer and mesothelioma. As the director of the Thoracic Oncology Program and professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, her research and clinical practice focuses on the development of new therapies for the treatment and prevention […]
Cancer Matters with Dr. Bill Nelson – Cancer Immunotherapy
Posted by | podcastDr Bill Nelson speaks with Dr Drew Pardoll, the Director of the Bloomberg~Kimmel Institute for Cancer Immunotherapy, about the progress being made in empowering patient's own immune system to combat their cancer.